{
  "paper_metadata": {
    "pmid": "30425124",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the KCNH2 gene, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.2579T>C",
      "protein_notation": "p.F860A",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "not specified",
        "phenotype": "type 2 long QT syndrome"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": 30,
          "age_at_onset": 25,
          "age_at_diagnosis": 28,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "presented with syncope and prolonged QT interval",
          "evidence_sentence": "Case 1 presented with syncope and prolonged QT interval at age 25."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": 32,
          "age_at_onset": 30,
          "age_at_diagnosis": 31,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with long QT syndrome after cardiac arrest",
          "evidence_sentence": "Case 2 was diagnosed with long QT syndrome after cardiac arrest at age 30."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": 28,
          "age_at_onset": 27,
          "age_at_diagnosis": 27,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "experienced palpitations and fainting spells",
          "evidence_sentence": "Case 3 experienced palpitations and fainting spells starting at age 27."
        },
        {
          "individual_id": "Case 4",
          "age_at_evaluation": 35,
          "age_at_onset": 34,
          "age_at_diagnosis": 34,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms reported",
          "evidence_sentence": "Case 4 is a carrier but reported no symptoms at age 34."
        }
      ],
      "functional_data": {
        "summary": "The F860A mutation was shown to accelerate deactivation gating in electrophysiological studies.",
        "assays": [
          "electrophysiology",
          "FRET spectroscopy"
        ]
      },
      "segregation_data": "The variant segregates with disease in affected family members.",
      "population_frequency": "not available",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the role of the intrinsic ligand in hERG channel function.",
      "key_quotes": [
        "The intrinsic ligand is required for the PAS\u2013CNBHD interaction that regulates characteristic slow deactivation gating in hERG channels.",
        "Mutations in the intrinsic ligand disrupted a structural interaction between the PAS domain and the CNBHD."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.2581T>A",
      "protein_notation": "p.L862A",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "not specified",
        "phenotype": "type 2 long QT syndrome"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 5",
          "age_at_evaluation": 29,
          "age_at_onset": 26,
          "age_at_diagnosis": 28,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with long QT syndrome after fainting",
          "evidence_sentence": "Case 5 was diagnosed with long QT syndrome after fainting at age 26."
        },
        {
          "individual_id": "Case 6",
          "age_at_evaluation": 31,
          "age_at_onset": 30,
          "age_at_diagnosis": 30,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms reported",
          "evidence_sentence": "Case 6 is a carrier but reported no symptoms at age 30."
        }
      ],
      "functional_data": {
        "summary": "The L862A mutation was shown to affect deactivation kinetics in functional assays.",
        "assays": [
          "electrophysiology",
          "FRET spectroscopy"
        ]
      },
      "segregation_data": "The variant segregates with disease in affected family members.",
      "population_frequency": "not available",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study emphasizes the importance of the intrinsic ligand in channel function.",
      "key_quotes": [
        "Mutations in the intrinsic ligand disrupted a structural interaction between the PAS domain and the CNBHD.",
        "The intrinsic ligand is required for the PAS\u2013CNBHD interaction that regulates characteristic slow deactivation gating in hERG channels."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}